In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors, such as ...

Researchers from the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) have applied AI-driven processes for detecting tertiary ...

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

But there’s a new emerging treatment of “neural grafts” that offers a more direct approach by aiming to replace the damaged brain cells themselves. In fact, significant clinical trials are ...

The team investigated an IgE antibody called MOv18, exploring its ability to activate immune cells from patients at Guy’s and St Thomas’ NHS Foundation Trust with ovarian cancer and its influence on ...

The Sarasota Memorial Research Institute is participating in a Phase 3 trial of an experimental drug for late-stage ovarian cancer ... that targets and kills cancer cells while leaving healthy ...

Declining cytoreductive surgery in advanced EOC is associated with significantly poorer survival outcomes compared to those who undergo the procedure. Sociodemographic factors, including race, age ...